EcoDrugPlus

Glutamate Metabotropic Receptor 3

Ensembl ID : ENSDCDG00000026677
Gene Symbol: GRM3
3 Cross references
212 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSDCDG00000020299
Gene Symbol: GRM4
3 Cross references
200 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSDCDG00000030378
Gene Symbol: GRM4
3 Cross references
214 Possible Orthologues:

Glutamate Metabotropic Receptor 5

Ensembl ID : ENSDCDG00000021063
Gene Symbol: GRM5
3 Cross references
222 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSDCDG00000021440
Gene Symbol: LOC114791862
3 Cross references
250 Possible Orthologues:

Glutamate Receptor 1-Like

Ensembl ID : ENSDCDG00000013797
Gene Symbol: LOC114782425
3 Cross references
252 Possible Orthologues:

Glutamate Receptor 2-Like

Ensembl ID : ENSDCDG00000020753
Gene Symbol: LOC114787528
3 Cross references
244 Possible Orthologues:

Glutamate Receptor 3-Like

Ensembl ID : ENSDCDG00000011825
Gene Symbol: LOC114767758
3 Cross references
199 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1

Ensembl ID : ENSDCDG00000035326
Gene Symbol: LOC114799129
3 Cross references
152 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 1-Like

Ensembl ID : ENSDCDG00000001575
Gene Symbol: LOC114785142
3 Cross references
204 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2a-Like

Ensembl ID : ENSDCDG00000003778
Gene Symbol: LOC114785597
2 Cross references
225 Possible Orthologues:

Glutamate Receptor Ionotropic, Nmda 2b-Like

Ensembl ID : ENSDCDG00000014226
Gene Symbol: LOC114785591
3 Cross references
256 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).